ACON
Aclarion, Inc.
NASDAQ · USHealthcareMedical - Healthcare Information Services
$2.63+1.94%
Price as of Jul 20, 2026
ACON growth
Aclarion, Inc. growth
Reported trailing growth, forward expectations and three-year compound growth rates.
Trailing growth
Year over year
- Revenue
- +42.6%
- EBITDA
- -25.5%
- EBIT
- -49.2%
- EPS
- +99.8%
- Free cash flow
- -57.8%
- Operating cash flow
- -29.5%
Forward estimates
- Revenue
- +3.4%
- EBITDA
- +99.0%
- EPS
- +16.7%
Three-year CAGR
- Revenue
- +7.8%
- EBITDA
- -11.8%
- EBIT
- -27.9%
- Net income
- -3.4%
- EPS
- +99.8%
- Free cash flow
- -28.5%
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.